Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 133

    1.

    Treatment with neutralizing antibodies specific for IL-1beta prevents cyclophosphamide-induced diabetes in nonobese diabetic mice.

    Cailleau C, Diu-Hercend A, Ruuth E, Westwood R, Carnaud C.

    Diabetes. 1997 Jun;46(6):937-40.PMID: 9166662 [PubMed - indexed for MEDLINE]Related articles

    2.

    Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis.

    O'Brien BA, Harmon BV, Cameron DP, Allan DJ.

    J Pathol. 2000 May;191(1):86-92.PMID: 10767724 [PubMed - indexed for MEDLINE]Related articles

    3.

    Effects of sodium fusidate in animal models of insulin-dependent diabetes mellitus and septic shock.

    Nicoletti F, Zaccone P, Di Marco R, Magro G, Grasso S, Morrone S, Santoni A, Tempera G, Meroni PL, Bendtzen K.

    Immunology. 1995 Aug;85(4):645-50.PMID: 7558161 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Analysis of action mechanism of lymphotoxin in prevention of cyclophosphamide-induced diabetes in NOD mice.

    Takahashi K, Satoh J, Sagara M, Zhu XP, Muto G, Muto Y, Fukuzawa M, Nishimura S, Miyaguchi S, Toyata T.

    J Autoimmun. 1995 Jun;8(3):335-46.PMID: 7575995 [PubMed - indexed for MEDLINE]Related articles

    7.

    IL-10 deficiency does not inhibit insulitis and accelerates cyclophosphamide-induced diabetes in the nonobese diabetic mouse.

    Balasa B, Van Gunst K, Jung N, Katz JD, Sarvetnick N.

    Cell Immunol. 2000 Jun 15;202(2):97-102.PMID: 10896769 [PubMed - indexed for MEDLINE]Related articles

    9.

    Islet-specific expression of IL-10 promotes diabetes in nonobese diabetic mice independent of Fas, perforin, TNF receptor-1, and TNF receptor-2 molecules.

    Balasa B, Van Gunst K, Jung N, Balakrishna D, Santamaria P, Hanafusa T, Itoh N, Sarvetnick N.

    J Immunol. 2000 Sep 1;165(5):2841-9.PMID: 10946317 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    IL-18 binding protein fusion construct delays the development of diabetes in adoptive transfer and cyclophosphamide-induced diabetes in NOD mouse.

    Zaccone P, Phillips J, Conget I, Cooke A, Nicoletti F.

    Clin Immunol. 2005 Apr;115(1):74-9.PMID: 15870024 [PubMed - indexed for MEDLINE]Related articles

    11.

    alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.

    Hammond KJ, Poulton LD, Palmisano LJ, Silveira PA, Godfrey DI, Baxter AG.

    J Exp Med. 1998 Apr 6;187(7):1047-56.PMID: 9529321 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Failure of exogenously administered interferon-gamma or blockage of endogenous interleukin-4 with specific inhibitors to augment the incidence of autoimmune diabetes in male NOD mice.

    Xiang M, Zaccone P, Di Marco R, Harris R, Magro G, Di Mauro M, Meroni PL, Garotta G, Nicoletti F.

    Autoimmunity. 1999;30(2):71-80.PMID: 10435719 [PubMed - indexed for MEDLINE]Related articles

    13.

    Human LT-alpha-mediated resistance to autoimmune diabetes is induced in NOD, but not NOD-scid, mice and abrogated by IL-12.

    Miyaguchi S, Satoh J, Takahashi K, Sakata Y, Nakazawa T, Miyazaki J, Toyota T.

    Clin Immunol. 2001 Jan;98(1):119-24.PMID: 11141334 [PubMed - indexed for MEDLINE]Related articles

    14.

    A self MHC class II beta-chain peptide prevents diabetes in nonobese diabetic mice.

    Chaturvedi P, Agrawal B, Zechel M, Lee-Chan E, Singh B.

    J Immunol. 2000 Jun 15;164(12):6610-20.PMID: 10843721 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Intramuscular injection of interleukin-10 plasmid DNA prevented autoimmune diabetes in mice.

    Zhang ZL, Shen SX, Lin B, Yu LY, Zhu LH, Wang WP, Luo FH, Guo LH.

    Acta Pharmacol Sin. 2003 Aug;24(8):751-6.PMID: 12904273 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    MFP14, a multifunctional emerging protein with immunomodulatory properties, prevents spontaneous and recurrent autoimmune diabetes in NOD mice.

    Panerai AE, Nicoletti F, Sacedote P, Arvidsson L, Conget I, Gomis R, Bartorelli A, Sandler S.

    Diabetologia. 2001 Jul;44(7):839-47.PMID: 11508268 [PubMed - indexed for MEDLINE]Related articles

    19.

    Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes.

    Trembleau S, Penna G, Gregori S, Magistrelli G, Isacchi A, Adorini L.

    J Immunol. 2000 Dec 15;165(12):6748-55.PMID: 11120794 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes.

    Amrani A, Verdaguer J, Thiessen S, Bou S, Santamaria P.

    J Clin Invest. 2000 Feb;105(4):459-68.PMID: 10683375 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data